St. Louis Financial Planners Asset Management LLC Decreases Position in Johnson & Johnson (NYSE:JNJ)

St. Louis Financial Planners Asset Management LLC lowered its position in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 20.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,087 shares of the company's stock after selling 2,850 shares during the quarter. Johnson & Johnson comprises 1.4% of St. Louis Financial Planners Asset Management LLC's investment portfolio, making the stock its 18th biggest holding. St. Louis Financial Planners Asset Management LLC's holdings in Johnson & Johnson were worth $1,839,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of JNJ. WealthTrak Capital Management LLC bought a new position in shares of Johnson & Johnson during the 4th quarter worth about $26,000. Mountain Hill Investment Partners Corp. bought a new position in shares of Johnson & Johnson during the 4th quarter worth about $29,000. Bay Harbor Wealth Management LLC bought a new position in shares of Johnson & Johnson during the 4th quarter worth about $32,000. Conquis Financial LLC bought a new position in shares of Johnson & Johnson during the 4th quarter worth about $33,000. Finally, Bernard Wealth Management Corp. bought a new position in shares of Johnson & Johnson during the 4th quarter worth about $36,000. Institutional investors own 69.55% of the company's stock.

Johnson & Johnson Stock Up 0.9%

NYSE:JNJ traded up $1.41 on Friday, hitting $154.99. The stock had a trading volume of 15,529,047 shares, compared to its average volume of 7,948,740. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.86 and a current ratio of 1.11. The stock has a market cap of $372.92 billion, a P/E ratio of 23.31, a price-to-earnings-growth ratio of 2.56 and a beta of 0.42. Johnson & Johnson has a 1 year low of $140.68 and a 1 year high of $169.99. The firm's fifty day simple moving average is $154.31 and its two-hundred day simple moving average is $153.65.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last posted its quarterly earnings data on Tuesday, April 15th. The company reported $2.77 EPS for the quarter, beating the consensus estimate of $2.59 by $0.18. The firm had revenue of $21.89 billion during the quarter, compared to analyst estimates of $21.65 billion. Johnson & Johnson had a net margin of 18.20% and a return on equity of 34.24%. Analysts predict that Johnson & Johnson will post 10.58 earnings per share for the current year.

Johnson & Johnson Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 10th. Shareholders of record on Tuesday, May 27th will be paid a $1.30 dividend. This is a positive change from Johnson & Johnson's previous quarterly dividend of $1.24. The ex-dividend date of this dividend is Tuesday, May 27th. This represents a $5.20 annualized dividend and a yield of 3.36%. Johnson & Johnson's dividend payout ratio (DPR) is 57.84%.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. Guggenheim reissued a "neutral" rating on shares of Johnson & Johnson in a research report on Wednesday, April 2nd. Leerink Partnrs cut shares of Johnson & Johnson from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, May 13th. Wall Street Zen cut shares of Johnson & Johnson from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 22nd. Benchmark raised shares of Johnson & Johnson to a "strong-buy" rating in a research report on Thursday, April 24th. Finally, Morgan Stanley raised their price target on shares of Johnson & Johnson from $164.00 to $169.00 and gave the company an "equal weight" rating in a research report on Wednesday, April 16th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $170.88.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.